CN102584856A - Method for preparing cefpirome sulfate - Google Patents

Method for preparing cefpirome sulfate Download PDF

Info

Publication number
CN102584856A
CN102584856A CN2012100336530A CN201210033653A CN102584856A CN 102584856 A CN102584856 A CN 102584856A CN 2012100336530 A CN2012100336530 A CN 2012100336530A CN 201210033653 A CN201210033653 A CN 201210033653A CN 102584856 A CN102584856 A CN 102584856A
Authority
CN
China
Prior art keywords
cefpirome
reaction
cefpirome sulfate
preparation
sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012100336530A
Other languages
Chinese (zh)
Inventor
李晓天
周振
陈水库
方水霞
孟庆乐
满喜霞
任立志
刘钦松
付晓宁
王建春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HENAN FUREN MEDICAL TECHNOLOGY DEVELOPMENT Co Ltd
KAIFENG YUGANG PHARMACEUTICAL CO Ltd
Original Assignee
HENAN FUREN MEDICAL TECHNOLOGY DEVELOPMENT Co Ltd
KAIFENG YUGANG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HENAN FUREN MEDICAL TECHNOLOGY DEVELOPMENT Co Ltd, KAIFENG YUGANG PHARMACEUTICAL CO Ltd filed Critical HENAN FUREN MEDICAL TECHNOLOGY DEVELOPMENT Co Ltd
Priority to CN2012100336530A priority Critical patent/CN102584856A/en
Publication of CN102584856A publication Critical patent/CN102584856A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a novel method for synthesizing cefpirome sulfate serving as a cephalosporin antibiotic, and belongs to the field of medicinal chemistry. The method comprises the following steps of: performing substitution reaction on (6R,7R)-3-(acetoxyl)methyl-7-2-amino-4-thiazolyl-(methoxyimino)acetylamino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-formic acid serving as an initial raw material and 2,3-cyclopentene pyridine, and performing salt forming reaction on a reaction product and sulfuric acid to obtain the cefpirome sulfate product. By the method, three-step reaction in the step (1) is continuously performed in the same reactor; and an expensive silicon reagent is not used, so that production cost is reduced, and the synthesis process is simple, convenient to operate and favorable for industrial production.

Description

The preparation method of Cefpirome Sulfate
Technical field
The present invention relates to a kind of the 4th generation cephalosporins the preparation method, especially relate to the preparation method of Cefpirome Sulfate, belong to the pharmaceutical chemistry field.
Background technology
Cefpirome belong to the 4th generation cephalosporins; Cefpirome is prepared into vitriol usually; Its chemistry is by name: (6R; 7R)-[(Z)-2-(thiazolamine-4-yl)-2-methoxyimino kharophen]-3-(6,7-dihydro-5H-cyclopentyl [b] pyridine-1-base-methyl)-8-oxo-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxyl monosulfate.Cefpirome Sulfate, went on the market in global twenties countries owing to its ultra spectrographic anti-microbial activity at first in Mexico and Sweden's listing in 1992 now.Have the zwitterionic characteristic of quaternary amine in the cefpirome structure, the superior bacterial outer membrane effect that sees through is arranged, high with penicillin-binding protein avidity, through hindering the synthetic anti-microbial effect that plays of bacteria cell wall.Be specially adapted to neutrophil leucocyte clinically and reduce patient's infection, lower respiratory tract severe infections, septicemia, urethra accompanying infection and skin and soft tissue infection up and down.
The synthetic route of cefpirome mainly contains two kinds at present: 1) 7-amino-cephalosporanic acid (7-ACA) obtains cefotaxime with amino thiophene oxime acid derivative generation acylation reaction, and again with 2,3-cyclopenta pyridine generation substitution reaction obtains cefpirome.2) with 2,3-cyclopenta pyridine generation substitution reaction obtains the pyridine substituent (7-ACP) of 7-ACA to 7-amino-cephalosporanic acid (7-ACA) earlier, obtains cefpirome with amino thiophene oxime acid or its active substance generation acylation reaction again.Wherein route 2 synthetic routes are long, complicated operation, and severe reaction conditions is unfavorable for large-scale industrial production; Cefotaxime and 2 in the route 1; 3-cyclopenta pyridine generation substitution reaction obtains in the process of cefpirome; Need with expensive silica reagent and iodide, severe reaction conditions causes its application prospect to be restricted; Therefore it is lower to develop cost, and the synthetic route of cefpirome easy and simple to handle is significant to large-scale industrial production.
 
Summary of the invention
The object of the invention provides a kind of improved Cefpirome Sulfate (6R; 7R)-[(Z)-2-(thiazolamine-4-yl)-2-methoxyimino kharophen]-3-(6; 7-dihydro-5H-cyclopentyl [b] pyridine-1-base-methyl)-and the compound method of 8-oxo-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxyl monosulfate, make it easy to operate, synthetic route is simplified; Cost reduces, and is fit to suitability for industrialized production.
For realizing the object of the invention; The present invention is with (6R; 7R)-3-(acetoxyl group) methyl-7-2-amino-4-thiazolyl-(methoxyimino) acetylaminohydroxyphenylarsonic acid 8-oxo-5-thia-1-azabicyclo 4.2.0 oct-2-ene-2-formic acid (cefotaxime) and 2; The 3-cyclopenta pyridine is a starting raw material, obtains the Cefpirome Sulfate product through substitution reaction and salt-forming reaction, and synthetic route is following:
Figure 2012100336530100002DEST_PATH_IMAGE001
Concrete through the following steps realization:
(1), cefotaxime is placed the mixed solvent of organic solvent and water, add alkali and catalyzer, stirring and dissolving adds 2 then, the reaction of 3-cyclopenta pyridine, and after reaction was accomplished, decolorizing with activated carbon obtained cefpirome solution.
(2), in step (1) gained cefpirome solution, add sulphuric acid soln and be carried out to reactant salt, crystallization obtains the Cefpirome Sulfate product.
Organic solvent described in the step (1) is generally acetone, acetonitrile or dioxane; The weight ratio of organic solvent and water is 1:5-5:1; Alkali is generally one or more the mixture in sodium hydrogencarbonate, saleratus, the triethylamine; Catalyzer is generally NaI, KI, KSCN, NaSCN etc.; Temperature of reaction is between-10-45 ℃; Reaction times is 1-6 hour.
The volumetric molar concentration of the sulphuric acid soln described in the step (2) is 1 mol-8 mol; In the solution that salt-forming reaction obtains, drip the acetone crystallization, filter, drying obtains Cefpirome Sulfate.
The present invention is with (6R; 7R)-3-(acetoxyl group) methyl-7-2-amino-4-thiazolyl-(methoxyimino) acetylaminohydroxyphenylarsonic acid 8-oxo-5-thia-1-azabicyclo 4.2.0 oct-2-ene-2-formic acid (cefotaxime) is raw material, obtains Cefpirome Sulfate through improved synthesis technique.In the wherein substitution reaction step, realized that three-step reaction carries out continuously in same reactor drum, and do not adopted expensive silica reagent that reduced production cost, synthesis route is simple, and is easy to operate, helps suitability for industrialized production.
Embodiment
For embodiment of the present invention better, lift embodiment at present the present invention is described further, but embodiment not a limitation of the present invention.
Embodiment: (6R; 7R)-[(Z)-2-(thiazolamine-4-yl)-2-methoxyimino kharophen]-preparation of 3-(6,7-dihydro-5H-cyclopentyl [b] pyridine-1-base-methyl)-8-oxo-5-thia-1-azabicyclic [4.2.0] oct-2-ene-2-carboxyl monosulfate
In the reaction flask of 500mL, add 45g (6R, 7R)-3-(acetoxyl group) methyl-7-2-amino-4-thiazolyl-(methoxyimino) acetylaminohydroxyphenylarsonic acid 8-oxo-5-thia-1-azabicyclo 4.2.0 oct-2-ene-2-formic acid, 125mL H 2The mixed solvent of O and 275 mL acetone adds 8.4 NaHCO then 3And 16gNaI,, be stirred to dissolving fully, add 12g 2, the 3-cyclopenta pyridine, 40 ℃ of reaction 2h, the HPLC detection reaction reaches terminal point, adds the 5g gac, filters, and obtains cefpirome solution.
In the reaction flask of 5L, add above-mentioned cefpirome solution and the dilution heat of sulfuric acid of 38 mL 6mol/L, behind the stirring 1h, in 2h, drip 2540 mL acetone solvents; Stirring at room 4 hours is cooled to below 10 ℃ filtering for crystallizing; The filter cake that obtains is used the 100mL washing with acetone; 40 ℃ of vacuum-dryings obtain 39.8g Cefpirome Sulfate solid, yield 65%.

Claims (4)

1. the preparation method of a Cefpirome Sulfate is characterized in that, realizes through following steps:
(1), with (6R; 7R)-3-(acetoxyl group) methyl-7-2-amino-4-thiazolyl-(methoxyimino) acetylaminohydroxyphenylarsonic acid 8-oxo-5-thia-1-azabicyclo 4.2.0 oct-2-ene-2-formic acid places the mixed solvent of organic solvent and water; Add alkali and catalyzer, stirring and dissolving; Add 2 then, the reaction of 3-cyclopenta pyridine, decolorizing with activated carbon obtains cefpirome solution; Catalyzer is selected NaI, KI, KSCN or NaSCN for use;
(2), in step (1) gained cefpirome solution, add sulphuric acid soln and be carried out to reactant salt, crystallization is filtered and is obtained the Cefpirome Sulfate product.
2. the preparation method of Cefpirome Sulfate as claimed in claim 1 is characterized in that, organic solvent is selected acetone, acetonitrile or dioxane for use; The weight ratio of organic solvent and water is 1:5-5:1.
3. the preparation method of Cefpirome Sulfate as claimed in claim 1 is characterized in that, alkali is selected one or more the mixture in sodium hydrogencarbonate, saleratus, the triethylamine for use.
4. like the preparation method of claim 1,2 or 3 described Cefpirome Sulfates, it is characterized in that, step (1) temperature of reaction is-10-45 ℃, the reaction times is 1-6 hour.
CN2012100336530A 2011-12-27 2012-02-15 Method for preparing cefpirome sulfate Pending CN102584856A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012100336530A CN102584856A (en) 2011-12-27 2012-02-15 Method for preparing cefpirome sulfate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201110442698.9 2011-12-27
CN201110442698 2011-12-27
CN2012100336530A CN102584856A (en) 2011-12-27 2012-02-15 Method for preparing cefpirome sulfate

Publications (1)

Publication Number Publication Date
CN102584856A true CN102584856A (en) 2012-07-18

Family

ID=46474174

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012100336530A Pending CN102584856A (en) 2011-12-27 2012-02-15 Method for preparing cefpirome sulfate

Country Status (1)

Country Link
CN (1) CN102584856A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646542A (en) * 2016-03-09 2016-06-08 上海宁瑞生化技术有限公司 Method using microwave method to synthesize cefpirome sulfate

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071979A (en) * 1981-05-12 1991-12-10 Hoechst Aktiengesellschaft Cephalosporin derivatives
CN101224195A (en) * 2008-01-18 2008-07-23 山东罗欣药业股份有限公司 Compounding method of cefpirome sulfate raw material and uses thereof
CN101284840A (en) * 2008-05-29 2008-10-15 管小明 Synthetic method of cefpirome sulfate
CN101323623A (en) * 2008-07-31 2008-12-17 中国药科大学 Novel fourth generation cephalosporin, preparation and use thereof
KR20090063817A (en) * 2007-12-14 2009-06-18 (주) 성운파마코피아 Direct method for preparing crystalline acid-added salts of cephem derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071979A (en) * 1981-05-12 1991-12-10 Hoechst Aktiengesellschaft Cephalosporin derivatives
KR20090063817A (en) * 2007-12-14 2009-06-18 (주) 성운파마코피아 Direct method for preparing crystalline acid-added salts of cephem derivatives
CN101224195A (en) * 2008-01-18 2008-07-23 山东罗欣药业股份有限公司 Compounding method of cefpirome sulfate raw material and uses thereof
CN101284840A (en) * 2008-05-29 2008-10-15 管小明 Synthetic method of cefpirome sulfate
CN101323623A (en) * 2008-07-31 2008-12-17 中国药科大学 Novel fourth generation cephalosporin, preparation and use thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GIORGIO ABBIATI,等: "Sequential Amination/Annulation/Aromatization Reaction of Carbonyl Compounds and Propargylamine: A New One-Pot Approach to Functionalized Pyridines", 《J. ORG. CHEM.》 *
ROSANNE BONJOUKLIAN,等: "Reactions of TMSI with cephalosporin esters", 《TETRAHEDRON LETTERS》 *
于文博,等: "头孢匹罗的合成进展", 《化学与生物工程》 *
刘晓,等: "硫酸头孢匹罗的合成工艺改进", 《中国药物化学杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646542A (en) * 2016-03-09 2016-06-08 上海宁瑞生化技术有限公司 Method using microwave method to synthesize cefpirome sulfate
CN105646542B (en) * 2016-03-09 2018-06-01 上海宁瑞生化技术有限公司 The method that microwave method synthesizes Cefpirome Sulfate

Similar Documents

Publication Publication Date Title
CN102372728B (en) Synthesizing method for cephalosporin compound
CN102372729B (en) Novel method for synthesizing cefoperazone sodium compound
CN102391289B (en) Synthetic methods of ceftazidime intermediate and ceftazidime
CN101108856A (en) Method of synthesizing antibiotics cefamandole nafate
CN100500671C (en) Synthesis process of cefpirome sulfate as antibiotic
CN105131017A (en) Preparation method for cefcapene pivoxil hydrochloride
CN101696214B (en) Cefminox sodium compound of new route
CN102030762A (en) Preparation method of cefprozil
CN104193765B (en) A kind of synthetic method of cefixime
CN103467496A (en) Preparing method of 7-((thiazolyl hydroxyl imino group) acetamido)-3-methyl cephalosporanic acid and another purpose
CN102633819A (en) Preparation method of cefoxitin
CN107266473B (en) A kind of synthetic method of cefotaxime
CN101798312B (en) Method for preparing cefprozil compound
CN105859747B (en) A kind of preparation method of cefepime Hydrochloride suitable for industrialized production
CN102584856A (en) Method for preparing cefpirome sulfate
CN103992337A (en) Convenient method for preparing aspoxicillin sodium
CN101550146A (en) Cefetamet pivoxil hydrochloride compound and preparation method thereof
CN101671348B (en) Ceftizoxime sosium compound of new way
CN102911186B (en) Ceftizoxime sodium preparation and refining method
CN102267953B (en) Intermediate compound for synthesizing Cefradine or Cefroxadine, and preparation method and application thereof
CN101486720B (en) Method for synthesizing cefodizime sodium compound
CN104817573A (en) Method for preparing cefepime dihydrochloride
CN114805393A (en) Preparation method of cefprozil
CN102532168A (en) Synthesis method of cefoperazone acid
CN113185538B (en) Preparation method of cefpodoxime acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120718